# B4GALT7

## Overview
The B4GALT7 gene encodes the enzyme beta-1,4-galactosyltransferase 7 (β1,4-GalT7), a type II transmembrane protein that plays a pivotal role in the biosynthesis of glycosaminoglycans (GAGs) within the extracellular matrix (ECM) of human cells. This enzyme is crucial for the initiation of GAG chain formation by catalyzing the transfer of the first galactose residue to the xylose of the tetrasaccharide linkage region, a key step in proteoglycan biosynthesis (Faiyaz‐Ul‐Haque2004A; RahuelClermont2010Biochemical). Proteoglycans, which are essential for maintaining the structural integrity and function of connective tissues, rely on the proper function of β1,4-GalT7 for their formation (Almeida1999Cloning). Mutations in B4GALT7 are linked to various connective tissue disorders, including certain forms of Ehlers-Danlos syndrome, highlighting the gene's clinical significance (Caraffi2019Severe; Guo2013Redefining).

## Function
The B4GALT7 gene encodes the enzyme beta-1,4-galactosyltransferase 7 (β1,4-GalT7), which plays a crucial role in the biosynthesis of glycosaminoglycans (GAGs) in healthy human cells. This enzyme is responsible for catalyzing the transfer of the first galactose residue to the xylose of the tetrasaccharide linkage region, which is essential for the initiation of GAG chain formation (RahuelClermont2010Biochemical). GAGs are important components of proteoglycans, which are predominantly found in the extracellular matrix (ECM) and are involved in various biological functions such as molecular organization of the ECM, cell adhesion, growth modulation, ionic filtration, and biomechanical lubrication (RahuelClermont2010Biochemical).

The enzyme β1,4-GalT7 is a type II transmembrane protein localized in the cis-Golgi, where it performs its catalytic function (Faiyaz‐Ul‐Haque2004A). It specifically catalyzes the formation of the Galβ1-4Xyl linkage in the proteoglycan linkage region, which is crucial for the biosynthesis of proteoglycans (Almeida1999Cloning). This function is critical for normal connective tissue function and integrity, as proteoglycans are essential for maintaining the structural integrity of tissues (Almeida1999Cloning).

## Clinical Significance
Mutations in the B4GALT7 gene are associated with several connective tissue disorders, primarily forms of Ehlers-Danlos syndrome (EDS). The progeroid variant of EDS, linked to B4GALT7 mutations, is characterized by joint laxity, skin hyperextensibility, poor wound healing, and short stature. Specific mutations such as p.Arg270Cys, p.Ala186Asp, and p.Leu206Pro have been identified, leading to reduced or lost enzyme activity, which affects glycosaminoglycan biosynthesis crucial for proteoglycan function in the extracellular matrix (Guo2013Redefining; RahuelClermont2010Biochemical).

Spondylodysplastic EDS (spEDS) is another condition associated with B4GALT7 mutations, characterized by severe joint laxity, short stature, and skeletal abnormalities. This condition is linked to mutations that impair the enzyme's function, leading to defective glycosylation of proteoglycans (Caraffi2019Severe; Lorenz2021Report).

B4GALT7 mutations can also result in perinatal lethal skeletal dysplasia, as observed in cases with compound heterozygous missense variants, indicating that severe loss of function can lead to lethal outcomes (Mihalic2019Expansion). Additionally, ocular anomalies such as corneal clouding and cataracts have been reported in association with B4GALT7 mutations (Mihalic2019Expansion).


## References


[1. (Lorenz2021Report) Delia Lorenz, Wolfram Kress, Ann-Kathrin Zaum, Christian P. Speer, and Helge Hebestreit. Report of two siblings with spondylodysplastic ehlers-danlos syndrome and b4galt7 deficiency. BMC Pediatrics, June 2021. URL: http://dx.doi.org/10.1186/s12887-021-02767-0, doi:10.1186/s12887-021-02767-0. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12887-021-02767-0)

[2. (Faiyaz‐Ul‐Haque2004A) Muhammad Faiyaz‐Ul‐Haque, Syed Hassan Ejaz Zaidi, Mariam Al‐Ali, Mariam S. Al‐Mureikhi, Shelley Kennedy, Ghalia Al‐Thani, Lap‐Chee Tsui, and Ahmad Said Teebi. A novel missense mutation in the galactosyltransferase‐i (b4galt7) gene in a family exhibiting facioskeletal anomalies and ehlers–danlos syndrome resembling the progeroid type. American Journal of Medical Genetics Part A, 128A(1):39–45, March 2004. URL: http://dx.doi.org/10.1002/ajmg.a.30005, doi:10.1002/ajmg.a.30005. This article has 85 citations.](https://doi.org/10.1002/ajmg.a.30005)

[3. (Almeida1999Cloning) Raquel Almeida, Steven B. Levery, Ulla Mandel, Hans Kresse, Tilo Schwientek, Eric P. Bennett, and Henrik Clausen. Cloning and expression of a proteoglycan udp-galactose:β-xylose β1,4-galactosyltransferase i. Journal of Biological Chemistry, 274(37):26165–26171, September 1999. URL: http://dx.doi.org/10.1074/jbc.274.37.26165, doi:10.1074/jbc.274.37.26165. This article has 202 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.37.26165)

[4. (RahuelClermont2010Biochemical) Sophie Rahuel-Clermont, Franck Daligault, Marie-Helene Piet, Sandrine Gulberti, Patrick Netter, Guy Branlant, Jacques Magdalou, and Virginie Lattard. Biochemical and thermodynamic characterization of mutated β1,4-galactosyltransferase 7 involved in the progeroid form of the ehlers–danlos syndrome. Biochemical Journal, 432(2):303–311, November 2010. URL: http://dx.doi.org/10.1042/bj20100921, doi:10.1042/bj20100921. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20100921)

[5. (Guo2013Redefining) Michael H. Guo, Joan Stoler, Julian Lui, Ola Nilsson, Diana W. Bianchi, Joel N. Hirschhorn, and Andrew Dauber. Redefining the progeroid form of ehlers–danlos syndrome: report of the fourth patient with b4galt7 deficiency and review of the literature. American Journal of Medical Genetics Part A, 161(10):2519–2527, August 2013. URL: http://dx.doi.org/10.1002/ajmg.a.36128, doi:10.1002/ajmg.a.36128. This article has 39 citations.](https://doi.org/10.1002/ajmg.a.36128)

[6. (Caraffi2019Severe) Stefano Giuseppe Caraffi, Ilenia Maini, Ivan Ivanovski, Marzia Pollazzon, Sara Giangiobbe, Maurizia Valli, Antonio Rossi, Silvia Sassi, Silvia Faccioli, Maja Di Rocco, Cinzia Magnani, Belinda Campos-Xavier, Sheila Unger, Andrea Superti-Furga, and Livia Garavelli. Severe peripheral joint laxity is a distinctive clinical feature of spondylodysplastic-ehlers-danlos syndrome (eds)-b4galt7 and spondylodysplastic-eds-b3galt6. Genes, 10(10):799, October 2019. URL: http://dx.doi.org/10.3390/genes10100799, doi:10.3390/genes10100799. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes10100799)

[7. (Mihalic2019Expansion) Theresa Mihalic Mosher, Deborah A. Zygmunt, Daniel C. Koboldt, Benjamin J. Kelly, Lisa R. Johnson, David S. McKenna, Benjamin C. Hood, Scott E. Hickey, Peter White, Richard K. Wilson, Paul T. Martin, and Kim L. McBride. Expansion of b4galt7 linkeropathy phenotype to include perinatal lethal skeletal dysplasia. European Journal of Human Genetics, 27(10):1569–1577, July 2019. URL: http://dx.doi.org/10.1038/s41431-019-0464-8, doi:10.1038/s41431-019-0464-8. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-019-0464-8)